Aldevron launches type-V CRISPR Nuclease
Aldevron, which develops and manufactures plasmid DNA, RNA and proteins for the biotech industry, has…
January 20, 2023 - 2 minutes
What’s new
The magical microbiome
By Brittany Niccum and Han Wei Now that we are past the holiday season and…
January 20, 2023 - 6 minutes
The future of single-cell microfluidics in cell engineering
By Richard Hammond, chief technical officer at Sphere Fluidics Single-cell microfluidic-based techniques continue to be…
January 20, 2023 - 3 minutes
New drug could replace current standard for treating brain cancer
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
January 20, 2023 - 3 minutes
DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…
January 20, 2023 - 2 minutes
Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project…
January 20, 2023 - 4 minutes
Netherlands Cancer Institute to use Proscia platform
Proscia, a provider of digital and computational pathology solutions, has announced that the Netherlands Cancer…
January 19, 2023 - 2 minutes
Cloned maggot enzyme wound treatment moves closer to reality
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its…
January 19, 2023 - 2 minutes
Avacta completes fourth dose escalation in tumor study
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the…
January 19, 2023 - 3 minutes
GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
January 19, 2023 - 2 minutes
Interview: Proscia talks about digital pathology
Labiotech recently interviewed Nathan Buchbinder, chief product officer at Proscia, about digital pathology. AI has…
January 19, 2023 - 8 minutes
Pathalys Pharma brings in $150M for SHPT trials
Pathalys Pharma, Inc. and Launch Therapeutics (Launch Tx) have announced a collaboration to advance phase…
January 19, 2023 - 3 minutes
